OncoZenge AB (publ) (ONCOZ.ST)

SEK 3.97

(4.34%)

Annual Cash Flows

(In SEK)
Breakdown 2023 2022 2021 2020
Operating Cash Flow -17.08 Million -22.07 Million -4.76 Million -1000.00
Net Income -15.9 Million -43.56 Million -4.89 Million -801 Thousand
Depreciation & Amortization - 23.16 Million - -
Deferred income taxes - -28.51 Million - -
Stock-based compensation - 296 Thousand - -
Change in working capital -1.18 Million -1.97 Million 127 Thousand 800 Thousand
Other non-cash items 1.18 Million 28.51 Million -1.13 Million -965 Thousand
Investing Cash Flow 570 Thousand - -5.35 Million -
Investments in PPE - - -5.35 Million -
Acquisitions - - - -
Investment purchases - - - -
Sales/Maturities of investments - - - -
Other Investing Activities 570 Thousand - -5.35 Million -
Financing Cash Flow 570 Thousand - 51.34 Million 10 Million
Debt repayment - - - -
Dividends payments - - - -
Common Stock Repurchased - - - -
Common Stock Issuance 570 Thousand - 51.34 Million 10 Million
Other Financing Activities - - 51.34 Thousand 10 Thousand
Accounts receivables 40 Thousand 11 Thousand 4.59 Million -
Accounts payables -1.22 Million -1.98 Million -4.47 Million 800 Thousand
Inventory 1.22 Million 1.98 Million 4.47 Million -
Other working capital -1.22 Million -1.98 Million -4.47 Million 800 Thousand
Cash at beginning of period 29.14 Million 51.21 Million 9.99 Million -
Cash at end of period 12.62 Million 29.14 Million 51.21 Million 9.99 Million
Capital Expenditure - - -5.35 Million -
Effect of forex changes on cash -570 Thousand - - -
Net cash flow / Change in cash -16.51 Million -22.07 Million 41.21 Million 9.99 Million
Free Cash Flow -17.08 Million -22.07 Million -10.12 Million -1000.00

Cash Flow Charts